Board
Directors
Isao Teshirogi, Ph.D. Representative Director, President and CEO

▼ Reasons for appointment
Isao Teshirogi became Representative Director and President in 2008. He has actively pushed forward with global research and development and expansion of global business to achieve the Third Medium-Term Business Plan and secured a medium- to long-term profit foundation. After achieving the quantitative targets of “Shionogi Growth Strategy 2020 (SGS2020),” formulated in FY2014, he updated the quantitative targets in October 2016 and also achieved these targets ahead of schedule. In 2020, he started a new Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030),” that includes the Company’s vision toward 2030, “Building Innovation Platforms to Shape the Future of Healthcare,” and has vigorously moved forward the business transformation with the aim of achieving further growth. He is also promoting the approval and the filing of an application for the approval of COVID-19 drugs and vaccines, respectively, as a pharmaceutical company that strives to counter infectious diseases.
- April 1982
-
Joined the Company
- January 1999
-
General Manager, Secretary Office and General Manager, Corporate Planning Department
- June 2002
-
Director of the Company
- October 2002
-
General Manager, Corporate Planning Department
- April 2004
-
Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
- April 2006
-
Senior Executive Officer and Executive General Manager, Pharmaceutical Research & Development Division
- April 2007
-
Senior Executive Officer
- April 2008
-
Representative Director and President and CEO of the Company
- June 2021
-
Outside Director of Sumitomo Mitsui Banking Corporation (incumbent)
- March 2022
-
Outside Director of AGC Inc. (incumbent)
- July 2022
-
Representative Director, President and CEO of the Company (incumbent)
- Major concurrent posts
-
Outside Director of Sumitomo Mitsui Banking Corporation
Outside Director, AGC Inc.
Attended all 12 Board of Directors meetings of FY2022.
Takuko Sawada Director and Vice Chairperson of the Board

▼ Reasons for appointment
Since her appointment as a Director of the Company in June 2015, Takuko Sawada has been responsible for business execution of the Corporate Strategy Division as Senior Vice President of the Corporate Strategy Division and as a Senior Executive Officer. She also moved Medium-Term Business Plan Shionogi Growth Strategy 2020 (SGS2020) forward, and played a central role in formulating the update of SGS2020 in October 2016. She became Vice President in April 2018 and has been supervising the Integrated Disease Care Division, Corporate Strategy Division, Pharmaceutical Commercial Division and DX promotion Division to achieve the new Medium-Term Business Plan “Shionogi Transformation Strategy 2030 (STS2030)” from April 2020. She has been in charge of supervising management from a higher standpoint as Director and Vice Chairperson since July 2022.
- April 1977
-
Joined the Company
- April 2002
-
Executive General Manager, Pharmaceutical Development Division
- April 2007
-
Officer and Executive General Manager, Pharmaceutical Development Division
- April 2010
-
Executive Officer and Executive General Manager, Pharmaceutical Development Division
- April 2011
-
Senior Executive Officer and Executive General Manager, Global Development Office
- April 2013
-
Senior Executive Officer and Senior Vice President, Global Development and, Pharmaceutical Development Division
- April 2014
-
Senior Executive Officer and Senior Vice President, Global Pharmaceutical Development Division
- April 2015
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- June 2015
-
Director of the Company and Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- October 2015
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division, and General Manager, Corporate Planning Department
- April 2016
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- April 2017
-
Senior Executive Officer and Senior Vice President, Corporate Strategy Division
- April 2018
-
Director of the Company and Executive Vice President
- Aplil 2020
-
Director of the Company and Executive Vice President and Senior Vice President of Integrated disease care Division
- July 2022
-
Director and Vice Chairperson of the Board (incumbent)
- June 2023
-
Outside Director of Konica Minolta Inc. (incumbent)
- Major concurrent posts
-
Outside Director, Konica Minolta Inc.
Attended all 12 Board of Directors meetings of FY2022.
Outside Directors
Keiichi Ando Outside Director(Independent Director)(Chairperson of the Board of Directors)

▼ Reasons for appointment
Keiichi Ando has practical experience as a corporate executive at a financial institution and broad insight on finance. He also coordinated the extremely difficult adjustments between the national government and the governments of Osaka Prefecture and Osaka City for the airport management business of Kansai, which was then at a crossroads, and his experience and insight built the foundation of Kansai Airports, which plays a leading role in the current Kansai economy. At the Company’s Board of Directors meetings, he presents many questions and opinions from the perspective of risk management and the use of assets that are important management resources. He also provides appropriate advice on budget planning and management and capital policies, including investments, while, as chair of the Board, taking into account the timeliness and appropriateness of the proposals. Thus, he recognizes the corporate responsibility we should fulfill and makes management decisions with an emphasis on objectivity and impartiality, without bias in favor of corporate executives or specific interested parties.
- April 1976
-
Joined Sumitomo Bank Limited (now Sumitomo Mitsui Banking Corporation)
- April 2003
-
Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2006
-
Managing Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2009
-
Director and Senior Managing Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2010
-
Representative Director and Deputy President and Executive Officer, Sumitomo Mitsui Banking Corporation
- April 2012
-
Representative Director and President, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD
- July 2012
-
Representative Director and President and CEO, NEW KANSAI INTERNATIONAL AIRPORT COMPANY, LTD.
- June 2016
-
Outside Director of the Company (incumbent)
- June 2016
-
Representative Director and President, GINSEN CO., LTD.
- June 2017
-
Outside Director of Tsubakimoto Chain Co. (incumbent)
- June 2019
-
Outside Director of DAIHEN Corporation (incumbent)
- Major concurrent posts
-
Outside Director, Tsubakimoto Chain Co.
Outside Director, DAIHEN Corporation
Attended all 12 Board of Directors meetings of FY2022.
Hiroshi Ozaki Outside Director(Independent Director)

▼ Reasons for appointment
Hiroshi Ozaki has abundant practical experience and wide-ranging knowledge in corporate management and organizational management as a manager of a company based in Kansai. He is also the former chairman of the Osaka Chamber of Commerce and Industry, and during his tenure promoted the economic growth of Osaka and Kansai based on the medium-term plan he developed, as well as focusing on promoting the life science industry. At the Company’s Board of Directors meetings, he points out problems appropriately and provides many supportive comments, such as advice on business and marketing, including production and distribution, and raising concerns regarding alliances. Accordingly, he makes management decisions with an emphasis on objectivity and neutrality based on his extensive experience and knowledge.
- May 1972
-
Joined Osaka Gas Co., Ltd.
- June 2000
-
Director, Osaka Gas Co., Ltd.
- June 2002
-
Director and Tokyo Representative, Osaka Gas Co., Ltd., on loan to the Japan Gas Association
- June 2005
-
Managing Director and General Manager of LNG Terminal and Power Generation Business Unit, Osaka Gas Co., Ltd.
- June 2007
-
Managing Director and General Manager of Commercial & Industrial Energy Business Unit, Osaka Gas Co., Ltd.
- April 2008
-
Representative Director and President, Osaka Gas Co., Ltd.
- June 2008
-
Director, Osaka Gas Chemicals Co., Ltd.
- June 2009
-
Representative Director and President, Operating Executive Officer, Osaka Gas Co., Ltd.
- June 2009
-
Director of OGIS-RI Co., Ltd.
- June 2011
-
Outside Director of Asahi Broadcasting Corporation (now Asahi Broadcasting Group Holdings Corporation)
- April 2015
-
Representative Director and Chairman, Osaka Gas Co., Ltd.
- June 2019
-
Outside Director of the Company (incumbent)
- January 2021
-
Director and Senior Advisor, Osaka Gas Co., Ltd.
- June 2021
-
Senior Advisor, Osaka Gas Co., Ltd. (incumbent)
- June 2021
-
Outside Director, The Royal Hotel, Ltd. (incumbent)
- Major concurrent posts
-
Outside Director, The Royal Hotel, Ltd.
Attended all 12 Board of Directors meetings of FY2022.
Fumi Takatsuki Outside Director(Independent Director)

▼ Reasons for appointment
Fumi Takatsuki has extensive experience and professional insight from her position as an attorney in international corporate law and in legal response relating to the Chinese life science and healthcare industry. Although she has not been involved in company management in any capacity other than as an outside director in the past, at the Company’s Board of Directors meetings, she points out problems and provides sound advice on issues that need to be considered, particularly concerning business expansion in Asia, including China, from the perspective of international corporate legal affairs. Accordingly, she makes fair management decisions from a global perspective, giving priority to legal compliance and social norms.
- October 2000
-
Registration of Attorney at Law
- October 2000
-
Joined Oike Law Offices
- December 2003
-
Joined Anderson Mori & Tomotsune Law Offices
- February 2004
-
Service at Beijing Office of Anderson Mori & Tomotsune Law Offices
- April 2006
-
Joined Oh-Ebashi LPC & Partners
- January 2009
-
Partner of Oh-Ebashi LPC & Partners (incumbent)
- June 2020
-
Outside Director of the Company (incumbent)
- June 2023
-
Outside Corporate Auditor of Sankyo Seiko Co., Ltd. (incumbent)
- Major concurrent posts
-
Partner of Oh-Ebashi LPC & Partners
Outside Corporate Auditor, Sankyo Seiko Co., Ltd.
Attended all 12 Board of Directors meetings of FY2022.
Takaoki Fujiwara Outside Director(Independent Director)

▼ Reasons for appointment
Takaoki Fujiwara has extensive practical experience and a wide range of knowledge as a manager of a group of companies engaged in urban transport, real estate, and entertainment, mainly in the Kansai area. He has served as the Company’s Corporate Auditor since June 2018. At the Board of Directors and Board of Corporate Auditors meetings, he provides appropriate advice mainly on compliance and human resource management, as well as auditing the appropriateness of management decisions and execution of duties by the directors from a broad perspective. We expect him to make appropriate and adequate management decisions in the 159th Term.
- April 1975
-
Joined Hanshin Electric Railway Co., Ltd.
- June 2005
-
Director, Hanshin Electric Railway Co., Ltd.
- June 2007
-
Managing Director, Hanshin Electric Railway Co., Ltd.
- April 2011
-
Representative Director and President, Hanshin Electric Railway Co., Ltd.
- June 2011
-
Director, Hankyu Hanshin Holdings, Inc.
- April 2015
-
Chairman and Representative Director, Hanshin Hotel Systems, Co., Ltd.
- April 2017
-
Chairman of the Board of Directors and Representative Director, Hanshin Electric Railway Co., Ltd.
- June 2017
-
Representative Director, Hankyu Hanshin Holdings, Inc.
- June 2017
-
Outside Director, Sanyo Electric Railway Co., Ltd. (incumbent)
- December 2017
-
Director, Hanshin Hotel Systems
- June 2018
-
Outside Corporate Auditor of the Company
- April 2023
-
Advisor of Hanshin Electric Railway Co., Ltd. (incumbent)
- June 2023
-
Outside Director of the Company (incumbent)
- Major concurrent posts
-
Outside Director, Sanyo Electric Railway Co., Ltd.
Attended all 12 Board of Directors meetings of FY2022.
Attended all 11 Board of Corporate Auditors meetings of FY2022.
Standing Corporate Auditors
Akira Okamoto Standing Corporate Auditor

▼ Reasons for appointment
Akira Okamoto has served as General Manager of administrative units, including the Business Support Center and the Personnel Department, and is well-versed in corporate management. He provides appropriate recommendations and advice on the management decisions and execution of duties by the Directors from an independent point of view as a Corporate Auditor, leveraging his experience in being involved in enhancing the Company’s corporate governance and upgrading and operating the internal control system as General Manager of the Internal Control Department.
Accordingly, we judge that he has the appropriate character and insight to perform the duties of a corporate auditor.
- April 1978
-
Joined the Company
- April 2006
-
General Manager, Business Support Center
- April 2007
-
General Manager, General Affairs & Personnel Department
- April 2008
-
General Manager, Human Resources Department
- April 2011
-
General Manager, Internal Control Department
- June 2015
-
Standing Corporate Auditor of the Company (incumbent)
Attended all 12 Board of Directors meetings of FY2022.
Attended all 11 Board of Corporate Auditors meetings of FY2022.
Ikuo Kato Standing Corporate Auditor

▼ Reasons for appointment
Mr. Ikuo Kato has served as General Manager of the Development Research Laboratories of the Company and as Representative Director and President and Chairman of subsidiary. He is not only well-versed in research and development, but has insight on corporate management. As Representative Director and President and Chairman of the subsidiary, he offers comments as necessary to the Shionogi Group’s management, and in our judgement, he provides appropriate recommendations and advice on management decisions and execution of duties from a neutral point of view as a corporate auditor.
- October 1988
-
Joined the Company
- April 2007
-
General Manager, Development Research Laboratories
- April 2010
-
General Manager, Drug Development Research Laboratories
- September 2010
-
General Manager, Drug Development Research Laboratories and Representative Director and President, Shionogi TechnoAdvance Research & Co., Ltd.
- April 2013
-
General Manager, Drug Development Research Laboratories and Representative Director and Chairman, Shionogi TechnoAdvance Research & Co., Ltd.
- April 2014
-
Representative Director and Chairman, Shionogi TechnoAdvance Research & Co., Ltd.
- June 2016
-
Standing Corporate Auditor of the Company (incumbent)
Attended all 12 Board of Directors meetings of FY2022.
Attended all 11 Board of Corporate Auditors meetings of FY2022.
Outside Corporate Auditors
Tsuguoki Fujinuma Outside Corporate Auditor(Independent Corporate Auditor)

▼ Reasons for appointment
Tsuguoki Fujinuma has professional expertise in finance and accounting. He has held many important posts, including Chairman and President of the Japanese Institute of Certified Public Accountants, and has extensive experience and broad insight as outside director and outside corporate auditor of a wide range of companies. Although he has not been involved in company management in any capacity other than as an outside executive in the past, he performs higher-quality audits of the Company from the perspective of finance and accounting based on his extensive experience as a certified public accountant. He also provides appropriate advice mainly from the finance, accounting, and sustainability viewpoint at the Board of Directors and Board of Corporate Auditors meetings.
Accordingly, we expect him to reflect his experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.
- April 1969
-
Joined Horie Morita Accounting Firm
- June 1970
-
Joined Arthur & Young Accounting Firm
- May 1986
-
Partner and Representative Partner of Asahi Shinwa Accounting Firm (now KPMG AZSA LLC)
- July 1993
-
Managing Partner of Ota Showa & Co. (now Ernst & Young ShinNihon LLC) (Resignation in June 2007)
- May 2000
-
President of the International Federation of Accountants (IFAC)
- July 2004
-
Chairman and President of the Japanese Institute of Certified Public Accountants
- February 2005
-
Trustee of the IFRS Foundation Trustees
- July 2007
-
Advisor of the Japanese Institute of Certified Public Accountants (incumbent)
- August 2007
-
Outside Director of Tokyo Stock Exchange Group (now Japan Exchange Group)
- October 2007
-
Governor of Tokyo Stock Exchange Regulation
- April 2008
-
Specially appointed Professor of Chuo Graduate School of Strategic Management (business School)
- June 2008
-
Outside Corporate Auditor of Sumitomo Corporation
- June 2008
-
Outside Corporate Auditor of Takeda Pharmaceutical Company Limited
- June 2008
-
Outside Director of Nomura Holdings, Inc.
- June 2008
-
Outside Director of Nomura Securities Co., Ltd.
- July 2008
-
Outside Director of Sumitomo Life Insurance Company
- February 2009
-
Trustee and Vice Chairman of the IFRS Foundation Trustees
- April 2010
-
Visiting Professor at Kansai University (incumbent)
- May 2010
-
Outside Corporate Auditor of Seven & i Holdings Co., Ltd.
- April 2015
-
Fellow (incumbent) and Advisory Board Member at Chuo University Business School
- July 2017
-
Auditor, Chiba Gakuen Educational Association (incumbent)
- June 2018
-
Chairman of Association of Certified Fraud Examiners Japan
- June 2019
-
Outside Corporate Auditor of the Company (incumbent)
- June 2023
-
Councilor of Association of Certified Fraud Examiners Japan (incumbent)
- Major concurrent posts
-
Auditor, Chiba Gakuen Educational Association
Attended all 12 Board of Directors meetings of FY2022.
Attended all 11 Board of Corporate Auditors meetings of FY2022.
Shuichi Okuhara Outside Corporate Auditor(Independent Corporate Auditor)

▼ Reasons for appointment
Shuichi Okuhara is qualified as a certified public accountant and has professional expertise in finance and accounting. We believe that he will be able to carry out audits suitable for the continually changing business environment based on his experience as Board member of Nippon Venture Capital Co., Ltd. in a social environment that places importance on peer or cross-industrial partnerships.
- April 1994
-
Joined Andersen Consulting Co., Ltd. (now Accenture Japan Ltd.)
- January 1998
-
Joined Nippon Venture Capital
- June 2008
-
Director and Investment manager of Nippon Venture Capital
- April 2009
-
Representative Director and President of Nippon Venture Capital
- June 2019
-
Representative Director and Chairman of Nippon Venture Capital (incumbent)
- June 2020
-
Outside Corporate Auditor of the Company (incumbent)
- Major concurrent posts
-
Representative Director and Chairman of Nippon Venture Capital (incumbent)
Attended all 12 Board of Directors meetings of FY2022.
Attended all 11 Board of Corporate Auditors meetings of FY2022.
Yoriko Goto Outside Corporate Auditor(Independent Corporate Auditor)

▼ Reasons for appointment
Yoriko Goto has professional expertise in finance and accounting as a certified public accountant and extensive management experience and broad insight through her service as Chairperson of the Board of Deloitte Tohmatsu Group and Deloitte Touche Tohmatsu LLC, among others. As she also serves as outside director of a financial institution, we believe that she will audit the Company from the finance, accounting, and management viewpoint.
Accordingly, we expect her to reflect her experience in the audits of the Company concerning the appropriateness of the management decisions and execution of duties by the directors from an independent point of view as an outside corporate auditor.
- November 1983
-
Joined Deloitte Haskins and Sells International (now Deloitte Touche Tohmatsu LLC)
- June 1996
-
Partner of Deloitte Touche Tohmatsu Limited (now Deloitte Touche Tohmatsu LLC)
- June 2007
-
Japan Leader of Global Financial Services Industry, Deloitte Touche Tohmatsu Limited
- October 2010
-
Managing Partner of Financial Services Industry, Deloitte Touche Tohmatsu LLC
- October 2013
-
Member of Executive Committee of Deloitte Touche Tohmatsu LLC and Member of Board of Deloitte Touche Tohmatsu Limited
- June 2018
-
Chairperson of the Board of Deloitte Touche Tohmatsu LLC and Deloitte Tohmatsu Group, and Member of Board of Deloitte Touche Tohmatsu Limited
- November 2018
-
Member of Board of Deloitte Asia Pacific Limited
- October 2022
-
President of Yoriko Goto CPA Office (incumbent)
- October 2022
-
Outside Director (Member of the Audit and Supervisory Committee) of Sumitomo Mitsui Banking Corporation (incumbent)
- June 2023
-
Outside Corporate Auditor of the Company (incumbent)
- Major concurrent posts
-
Outside Director (Member of the Audit and Supervisory Committee) of Sumitomo Mitsui Banking Corporation
Corporate Officers
Senior Executive Officer, Senior Vice President, Supply Supervisory Unit and Global Business Division | Koji Hanasaki, Ph.D. |
---|---|
Senior Executive Officer, Senior Vice President, R&D Supervisory Unit | John Keller, Ph.D. |
Senior Executive Officer, Senior Vice President, Healthcare Business Supervisory Unit and Pharmaceutical Commercial Division | Toshinobu Iwasaki, Ph.D. |
Senior Executive Officer, Senior Vice President, Corporate Supervisory Unit | Noriyuki Kishida |
Senior Executive Officer, Senior Vice President, Administration Division | Kazuhiro Hatanaka |
Senior Executive Officer, Senior Vice President, Corporate Strategy Division | Ryuichi Kiyama, Ph.D. |
Senior Executive Officer, Senior Vice President, Research Division | Yasuyoshi Isou, Ph.D. |
Corporate Officer, Senior Vice President, Corporate Quality Assurance and Ethics & Compliance Management Division | Takeshi Shiota, Ph.D. |
Corporate Officer, President, Shionogi Pharma Co., Ltd | Akira Kato, Ph.D. |
Corporate Officer, Chairman and CEO of Ping An Shionogi Company Ltd. and Ping An Shionogi (Hong Kong) Company Ltd. |
Tatsumori Yoshida |
Corporate Officer, Senior Vice President, DX Promotion Division | Masashi Deguchi, Ph.D. |
Corporate Officer, Senior Vice President, Biopharmaceutical Research Division | Yasunori Aoyama, Ph.D. |
Corporate Officer, Senior Vice President, Integrated Disease Care Division | Yousuke Miharu |
Corporate Officer, Senior Vice President, Drug Development and Regulatory Science Division | Takeki Uehara, Ph.D. |
Corporate Officer, Vice President, Pharmaceutical Commercial Division | Yoshinori Yurugi |
Corporate Officer, President, Shionogi Healthcare Co., Ltd | Satoru Yoshimoto |